Phase III study to evaluate the effect of 10 percent metronidazole ointment, applied topically three times a day in and around the anus and the change in perianal Crohn's disease activity
Phase of Trial: Phase III
Latest Information Update: 12 Dec 2012
At a glance
- Drugs Metronidazole (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Sponsors SLA Pharma
- 16 Oct 2008 Actual end date (Feb 2008) added as reported by ClinicalTrials.gov.
- 16 Oct 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Aug 2007 New trial record.